Efficacy and Safety of Tolvaptan in Treatment of SIADH; Case-Series From 2 UK Hospitals

Endocrine Abstracts
doi 10.1530/endoabs.37.ep732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Progressive Reduction of Tolvaptan Doses in the Treatment of Chronic SIADH

Endocrine Abstracts
2015English

Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Efficacy and Safety of a 14-Day Administration of Tolvaptan in the Treatment of Patients With Ascites in Hepatic Oedema

Journal of International Medical Research
BiochemistryMedicineCell Biology
2013English

Linagliptin: Farmacology, Efficacy and Safety in Type 2 Diabetes Treatment

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Efficacy and Safety of Oral Tolvaptan Therapy in Patients With the Syndrome of Inappropriate Antidiuretic Hormone Secretion

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2011English

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

American Journal of Nephrology
Nephrology
2017English

A UK Case Series of Phaco-Ecp

Advances in Ophthalmology & Visual System
2015English

Management of Patients With Issues Related to Opioid Safety, Efficacy and/or Misuse: A Case Series From an Integrated, Interdisciplinary Clinic

Addiction science & clinical practice
PsychiatryClinical PsychologyMental Health
2016English

Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma

Clinical Medicine Insights: Oncology
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy